Picture a world where people routinely die from minor infections, where invasive surgery like organ transplants can’t be performed because it’s too risky, and where hospital wards are breeding grounds for disease.
As science evolves we are learning that the immune system does so much more than protect us from an outside attack.
People affected by rare diseases often face extraordinary barriers. They can find it difficult to get the right diagnosis, expert advice or treatment and support.
Patients and consumers
329 million people suffer from COPD worldwide. A further 235 million suffer from asthma. We are on a journey to help everyone breathe better and live the life they want.
Scientists are discovering just how important microbes are in maintaining our respiratory health and immunity
How we do business
From June 2016, we will publicly disclose information on payments and transfers of value that we make to doctors and other healthcare professionals (HCPs) in Europe as part of an initiative by the European Federation of Pharmaceutical Industries and Associations (EFPIA).